Research Summary

Tighter glycaemic targets may reduce serious infant morbidity

Moderate confidence
Low bias
Last updated June 15, 2026

Key Takeaway:

This study evaluated the impact of tighter glycaemic control in women with gestational diabetes. It found a reduction in serious health outcomes for infants but an increase in serious maternal health outcomes.

Study at a Glance

Participants

Intervention

Tighter glycemic control, Less tight glycemic control

Outcomes

Large for gestational age, Composite serious health outcome for the infant, Serious maternal health outcome, Pharmacological treatment requirement

Funding

Non-Industry Sponsored

Save this study and add notes to your research library.

Main Effects

The rate of large for gestational age was similar between groups (14.7% vs 15.1%; P = 0.839).

The composite serious health outcome for infants was reduced in the tighter group (1.3% vs 2.6%; P = 0.032).

Shorter length of stay in intensive care was observed in the tighter group (P = 0.041).

Serious maternal health outcomes increased in the tighter group (5.9% vs 3.0%; P = 0.020).

Evidence Summary

InterventionOutcomeMeasured ChangeStudy Effect
Procedures
Less tight glycemic control
(Procedures)
Clinical Outcomes
Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)
(Clinical Outcomes)
Decrease
Strong
Procedures
Less tight glycemic control
(Procedures)
Clinical Outcomes
Serious maternal health outcome
(Clinical Outcomes)
Increase
Unclear
Procedures
Less tight glycemic control
(Procedures)
Safety
Serious perinatal adverse events
(Safety)
No Change
Unclear
Procedures
Tighter glycemic control
(Procedures)
Clinical Outcomes
Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)
(Clinical Outcomes)
Decrease
Strong
Procedures
Tighter glycemic control
(Procedures)
Clinical Outcomes
Serious maternal health outcome
(Clinical Outcomes)
Increase
Unclear
Procedures
Tighter glycemic control
(Procedures)
Safety
Serious perinatal adverse events
(Safety)
No Change
Unclear

Unlock Full Evidence Analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

Evidence Suggest

  • Tighter glycaemic control reduced serious health outcomes for infants (1.3% vs 2.6%; P = 0.032).
  • Increased serious maternal health outcomes in the tighter group (5.9% vs 3.0%; P = 0.020).
  • More women required pharmacological treatment with tighter targets (67.9% vs 58.5%; P = 0.047).
who this applies

Who this applies to

  • Women diagnosed with gestational diabetes.
  • Pregnant women requiring glycaemic management.
keep in mind

Keep in Mind

  • Results may not apply to all populations with gestational diabetes.
  • The study did not account for all potential confounding variables.
  • Further research is needed to explore long-term outcomes for mothers and infants.
between the lines

Between the Lines

  • The study's design may limit generalizability to broader populations.
  • Potential confounding factors were not fully controlled.
  • The sample size may affect the robustness of the findings.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Journal Reference

Caroline AC, Deborah S, Ruth H, et al. Tighter Glycaemic Targets in Women with Gestational Diabetes: A Stepped-Wedge Cluster-Randomised Trial. PLOS Medicine. 2022;19(9):e1004087. doi:10.1371/journal.pmed.1004087

Connected Evidence

Discover how this study fits into the broader diabetes evidence landscape.

This study contributes to evidence on Less tight glycemic control and Cardiovascular Outcomes, Tighter glycemic control and Cardiovascular Outcomes.

Related evidence relationships

Explore in Evidence Archive

This study contributes to the evidence on the following intervention–outcome relationships.

Explore more in the evidence archive

Jump to pre-filtered views in the evidence archive.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.